467 related articles for article (PubMed ID: 18985070)
1. Kallmann syndrome.
Dodé C; Hardelin JP
Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
[TBL] [Abstract][Full Text] [Related]
2. Clinical genetics of Kallmann syndrome.
Dodé C; Hardelin JP
Ann Endocrinol (Paris); 2010 May; 71(3):149-57. PubMed ID: 20362962
[TBL] [Abstract][Full Text] [Related]
3. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
Hardelin JP; Dodé C
Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetics of Kallmann syndrome: an update].
Fu C; Feng Z; Liu RZ
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
Tsai PS; Gill JC
Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
[TBL] [Abstract][Full Text] [Related]
7. Kallmann syndrome in women: from genes to diagnosis and treatment.
Meczekalski B; Podfigurna-Stopa A; Smolarczyk R; Katulski K; Genazzani AR
Gynecol Endocrinol; 2013 Apr; 29(4):296-300. PubMed ID: 23368665
[TBL] [Abstract][Full Text] [Related]
8. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
[TBL] [Abstract][Full Text] [Related]
9. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
Kim SH; Hu Y; Cadman S; Bouloux P
J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
[TBL] [Abstract][Full Text] [Related]
11. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
[TBL] [Abstract][Full Text] [Related]
12. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
[TBL] [Abstract][Full Text] [Related]
13. Genetic insights into human isolated gonadotropin deficiency.
Trarbach EB; Silveira LG; Latronico AC
Pituitary; 2007; 10(4):381-91. PubMed ID: 17624596
[TBL] [Abstract][Full Text] [Related]
14. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
[TBL] [Abstract][Full Text] [Related]
15. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
[TBL] [Abstract][Full Text] [Related]
16. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
[TBL] [Abstract][Full Text] [Related]
17. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
[TBL] [Abstract][Full Text] [Related]
18. Kallmann syndrome: fibroblast growth factor signaling insufficiency?
Dodé C; Hardelin JP
J Mol Med (Berl); 2004 Nov; 82(11):725-34. PubMed ID: 15365636
[TBL] [Abstract][Full Text] [Related]
19. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
Sarfati J; Dodé C; Young J
Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
[TBL] [Abstract][Full Text] [Related]
20. Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.
Costa-Barbosa FA; Balasubramanian R; Keefe KW; Shaw ND; Al-Tassan N; Plummer L; Dwyer AA; Buck CL; Choi JH; Seminara SB; Quinton R; Monies D; Meyer B; Hall JE; Pitteloud N; Crowley WF
J Clin Endocrinol Metab; 2013 May; 98(5):E943-53. PubMed ID: 23533228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
